292 related articles for article (PubMed ID: 24937811)
21. Understanding the type 1 reactional state for early diagnosis and treatment: a way to avoid disability in leprosy.
Nery JA; Bernardes Filho F; Quintanilha J; Machado AM; Oliveira Sde S; Sales AM
An Bras Dermatol; 2013; 88(5):787-92. PubMed ID: 24173185
[TBL] [Abstract][Full Text] [Related]
22. Chemoprophylaxis of leprosy with rifampicin in contacts of multibacillary patients: study protocol for a randomized controlled trial.
Dos Santos DS; Duppre NC; Sarno EN; Pinheiro RO; Sales AM; Nery JADC; Moraes MO; Camacho LAB
Trials; 2018 Apr; 19(1):244. PubMed ID: 29685164
[TBL] [Abstract][Full Text] [Related]
23. Active search for leprosy cases in Midwestern Brazil: a serological evaluation of asymptomatic household contacts before and after prophylaxis with bacillus Calmette-Guérin.
Limeira OM; Gomes CM; Morais OO; Cesetti MV; Alvarez RR
Rev Inst Med Trop Sao Paulo; 2013; 55(3):. PubMed ID: 23740009
[TBL] [Abstract][Full Text] [Related]
24. Comparison of quality of life evaluated by SF-36 and DLQI in multibacillary and paucibacillary leprosy patients from Sao Paulo, Brazil.
Guimenes Albuquerque R; Grüdtner Buratto G; Hirotsu C; Maeda SM; Floriano MC; Levy Andersen M; Tufik S; Tomimori J
Int J Dermatol; 2019 Dec; 58(12):1415-1422. PubMed ID: 31148144
[TBL] [Abstract][Full Text] [Related]
25. World Health Organization (WHO) antibiotic regimen against other regimens for the treatment of leprosy: a systematic review and meta-analysis.
Lazo-Porras M; Prutsky GJ; Barrionuevo P; Tapia JC; Ugarte-Gil C; Ponce OJ; Acuña-Villaorduña A; Domecq JP; De la Cruz-Luque C; Prokop LJ; Málaga G
BMC Infect Dis; 2020 Jan; 20(1):62. PubMed ID: 31959113
[TBL] [Abstract][Full Text] [Related]
26. Leprosy survey among rural communities and wild armadillos from Amazonas state, Northern Brazil.
Stefani MMA; Rosa PS; Costa MB; Schetinni APM; Manhães I; Pontes MAA; Costa P; Fachin LRV; Batista IMFD; Virmond M; Pereira E; Penna MLF; Penna GO
PLoS One; 2019; 14(1):e0209491. PubMed ID: 30629624
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of fixed duration multidrug therapy for the treatment of multibacillary leprosy: A prospective observational study from Northern India.
Singh I; Ahuja M; Lavania M; Pathak VK; Turankar RP; Singh V; Sengupta U; Das L; Kumar A; Saini GB
Indian J Dermatol Venereol Leprol; 2023; 89(2):226-232. PubMed ID: 36331863
[TBL] [Abstract][Full Text] [Related]
28. Multibacillary leprosy with an incubation period exceeding 50 years.
Taggart M; Kelly A; Stell R; Chu E
BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35790324
[TBL] [Abstract][Full Text] [Related]
29. Mycobacterium leprae DNA in peripheral blood may indicate a bacilli migration route and high-risk for leprosy onset.
Reis EM; Araujo S; Lobato J; Neves AF; Costa AV; Gonçalves MA; Goulart LR; Goulart IM
Clin Microbiol Infect; 2014 May; 20(5):447-52. PubMed ID: 24033793
[TBL] [Abstract][Full Text] [Related]
30. A colorimetric PCR method for the detection of M. leprae in skin biopsies from leprosy patients.
Jamil S; Wilson SM; Hacket M; Hussain R; Stoker NG
Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):512-20. PubMed ID: 7868947
[TBL] [Abstract][Full Text] [Related]
31. Immunotherapy with a mixture of Mycobacterium leprae and BCG in different forms of leprosy and in Mitsuda-negative contacts.
Convit J; Aranzazu N; Ulrich M; Pinardi ME; Reyes O; Alvarado J
Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):415-24. PubMed ID: 6763002
[TBL] [Abstract][Full Text] [Related]
32. Leprosy Reactions in Patients Coinfected with HIV: Clinical Aspects and Outcomes in Two Comparative Cohorts in the Amazon Region, Brazil.
Pires CA; Jucá Neto FO; de Albuquerque NC; Macedo GM; Batista Kde N; Xavier MB
PLoS Negl Trop Dis; 2015; 9(6):e0003818. PubMed ID: 26029928
[TBL] [Abstract][Full Text] [Related]
33. Leprosy.
Smith WC; Saunderson P
BMJ Clin Evid; 2010 Jun; 2010():. PubMed ID: 21418690
[TBL] [Abstract][Full Text] [Related]
34. Changes in the size and number of skin lesions in PB leprosy on treatment and follow-up.
Rao PN; Suneetha S; Pratap DV
Lepr Rev; 2011 Sep; 82(3):244-52. PubMed ID: 22125932
[TBL] [Abstract][Full Text] [Related]
35. Presence of M. leprae in tissues in slit skin smear negative multibacillary (MB) patients after WHO-MBR.
Sharma A; Sharma VK; Rajwanshi A; Das A; Kaur I; Kumar B
Lepr Rev; 1999 Sep; 70(3):281-6. PubMed ID: 10603717
[TBL] [Abstract][Full Text] [Related]
36. Single lesion paucibacillary leprosy: baseline profile of the Brazilian Multicenter Cohort Study.
Martelli CM; Stefani MM; Gomes MK; Rebello PF; Peninni S; Narahashi K; Maroclo AL; Costa MB; Silva SA; Sacchetim SC; Nery JA; Salles AM; Gillis TP; Krahenbuhl JL; Andrade AL
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):247-57. PubMed ID: 11221086
[TBL] [Abstract][Full Text] [Related]
37. Risk and protective factors for leprosy development determined by epidemiological surveillance of household contacts.
Goulart IM; Bernardes Souza DO; Marques CR; Pimenta VL; Gonçalves MA; Goulart LR
Clin Vaccine Immunol; 2008 Jan; 15(1):101-5. PubMed ID: 17989339
[TBL] [Abstract][Full Text] [Related]
38. Revalidation of various clinical criteria for the classification of leprosy--a clinic-pathological study.
Gupta R; Kar HK; Bharadwaj M
Lepr Rev; 2012 Dec; 83(4):354-62. PubMed ID: 23614253
[TBL] [Abstract][Full Text] [Related]
39. Interruption of persistent exposure to leprosy combined or not with recent BCG vaccination enhances the response to Mycobacterium leprae specific antigens.
de Carvalho FM; Rodrigues LS; Duppre NC; Alvim IMP; Ribeiro-Alves M; Pinheiro RO; Sarno EN; Pessolani MCV; Pereira GMB
PLoS Negl Trop Dis; 2017 May; 11(5):e0005560. PubMed ID: 28467415
[TBL] [Abstract][Full Text] [Related]
40. Development and evaluation of a droplet digital PCR assay for the diagnosis of paucibacillary leprosy in skin biopsy specimens.
Cheng X; Sun L; Zhao Q; Mi Z; Yu G; Wang Z; Sun Y; Wang C; Man C; Fu F; Liu H; Zhang F
PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007284. PubMed ID: 30883558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
